Too often, we tell our patients that 40 is the magic number — the age when breast cancer screening finally becomes a priority. But for Black women, that benchmark may not be adequate. I say this as a colleague, not a critic.
We work within guidelines developed with good intentions. But good intentions aren’t enough when the data clearly show we need to do better. Black women are 41 percent more likely to die from breast cancer than white women. Not because the disease itself discriminates, but because our system does. By the time many of our Black patients hit the standard screening age, the disease has already had years to take root. We’re not just missing early detection — we’re missing the window where early detection actually matters.
As the former president of the National Medical Association (NMA), I spent a lot of time asking myself the same question: what can we do differently? Breast cancer screening is one place where the answer is painfully clear — we have to stop waiting until 40.
It develops early. Many Black women develop breast cancer in their 20s and 30s, long before we’ve even started thinking about ordering a mammogram. If we’re not asking about risk until 40, we’re simply not looking at where the disease is actually showing up.
It grows faster. Black women are twice as likely to develop triple-negative breast cancer —an aggressive subtype that doesn’t respond to hormone therapies and demands immediate, specialized treatment. This isn’t a cancer that rewards a “wait and see” approach. Every month of delay is a month this disease doesn’t need to advance.
It gets dismissed. How many times have we heard a young patient mention a lump, and our first instinct is to reassure her it’s “probably nothing” because of her age? I get it — statistically, that instinct isn’t unreasonable for the general population. But for Black women, that instinct is exactly what’s killing us. A lump in a 28-year-old Black woman deserves the same seriousness as one in a 45-year-old woman of any other background.
Efforts to reduce breast cancers impact of the Black community starts with a conversation we should already be having by age 25 — not 40. Ask about family history. Not just the easy question of “Has your mother or sister had breast cancer?” but the harder follow-up: “What about aunts, grandmothers, cousins?” Cancer histories in Black families are often incomplete, shaped by decades of limited access to healthcare, lost records, or relatives who were never properly diagnosed in the first place. If the history feels incomplete, treat that incompleteness itself as a risk factor worth noting.
From there, talk about genetic testing. BRCA1 and BRCA2 mutations don’t check skin color before they show up, but conversations about genetic testing have historically centered on white patients. If a patient’s history even hints at elevated risk, that’s your opening to discuss testing — not as an afterthought, but as a standard part of her care.
Once you understand her risk, build a plan that actually reflects it. A patient with a strong family history or a known genetic mutation isn’t an “average risk” patient, and she shouldn’t be screened like one. For her, earlier and more frequent screening isn’t excessive — it’s appropriate.
And for every patient, regardless of risk category, we need to drop the habit of dismissing changes in young bodies. We see lumps in young women all the time. A lump, a change in texture, persistent pain — these deserve investigation, not reassurance. I’d rather order an unnecessary test than miss a cancer because I assumed age made it unlikely.
We can’t throw out the guidelines. I’m asking us to recognize that guidelines are a floor, not a ceiling — a starting point for the average patient, not a rule that overrides what we’re seeing in front of us. When the data tells us a population is dying at higher rates, developing cancer earlier, and facing more aggressive disease, we don’t get to shrug and say, “the guideline says 40.”
I believe the conversation about breast cancer at 25. Ask about family history like it matters, because it does. Take young patients seriously when they tell you something that feels wrong.
We can’t prevent every cancer, but we can stop letting a calendar date decide who lives and who doesn’t. That’s not medicine. That’s negligence. And fixing it? That part is entirely in our hands.
By subscribing, you consent to receive emails from BlackDoctor.pro You may unsubscribe at any time. Privacy Policy & Terms of Service.
Are you a healthcare professional? Register with us today!
